Jochims C, Mazitschek U, Jäger D, Goldschmidt H
Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany.
Internist (Berl). 2006 Jun;47(6):633-41. doi: 10.1007/s00108-006-1626-7.
The development and clinical introduction of targeted therapies has resulted in significant progress for the treatment of malignant diseases. These forms of therapy supplement traditional methods of chemotherapy, radiation, and surgery. As new therapies increase the complexity of therapeutic options in oncology, the treatment costs steadily climb as well. Parameters need to be identified which will predict a response to new substances, and this effort is the subject of ongoing studies.
靶向治疗的发展及临床应用已在恶性疾病治疗方面取得显著进展。这些治疗方式补充了传统的化疗、放疗及手术方法。随着新疗法增加了肿瘤学治疗选择的复杂性，治疗成本也在稳步攀升。需要确定能够预测对新物质反应的参数，而这正是正在进行的研究课题。
